Lots of attention is now being focused on migraines

June 2000

Lots of attention is now being focused on migraines...due to several new migraine drugs...plus new guidelines from the American Academy of Neurology.

Experts now recommend more aggressive treatment...to reduce the frequency and severity.

Suggest ASA or NSAIDs for mild to moderate migraines. These drugs have good anti-inflammatory activity...but many people don't take high enough doses.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Handheld computers
Vitamins & Minerals Institute of Medicine's new recommendations for vitamin E
Women's Health Crinone, a vaginal gel containing 8% micronized progesterone
Women's Health a new norethindrone-estradiol patch called Estalis
Women's Health a new norethindrone-estradiol patch called Estalis
Diabetes Lantus, a new long-acting insulin
a new sleeping pill, Starnoc (zaleplon)
new Alzheimer's drug, Exelon (rivastigmine)
Migraine Lots of attention is now being focused on migraines
NSAIDs new NSAID for osteoarthritis called Mobic (meloxicam)
NSAIDs Vioxx might increase the risk of heart attack
St. John's wort might reduce the effectiveness of oral contraceptives

Lots of attention is now being focused on migraines

Practical advice for a better career, with unlimited access to CE

Table of Contents